Product NDC: | 0378-3030 |
Proprietary Name: | Doxycycline Hyclate |
Non Proprietary Name: | doxycycline hyclate |
Active Ingredient(s): | 150 mg/1 & nbsp; doxycycline hyclate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-3030 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091052 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121220 |
Package NDC: | 0378-3030-05 |
Package Description: | 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0378-3030-05) |
NDC Code | 0378-3030-05 |
Proprietary Name | Doxycycline Hyclate |
Package Description | 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0378-3030-05) |
Product NDC | 0378-3030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | doxycycline hyclate |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20121220 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | DOXYCYCLINE HYCLATE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes |